P 53 codon 72 polymorphism in stomach and colorectal adenocarcinomas in Iranian patients

Indian Journal of Cancer

Volumn 47, Issue 1, 2010, Pages 31-34

  Mojtahedi, Z ^a   Haghshenas, M R ^a   Hosseini, S V ^b   Fattahi, M J ^a   Ghaderi, A ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Colorectal cancer; P53; Polymorphism; Stomach cancer

Indexed keywords

DNA; PROTEIN P53;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER PATIENT; CODON; COLON ADENOCARCINOMA; COLORECTAL CANCER; COLORECTAL CARCINOMA; CONTROLLED STUDY; DNA EXTRACTION; FEMALE; GENE; GENE FREQUENCY; GENETIC ASSOCIATION; GENOTYPE; HISTOPATHOLOGY; HUMAN; IRAN; MAJOR CLINICAL STUDY; MALE; P53 GENE; PERIPHERAL BLOOD MONONUCLEAR CELL; POLYMERASE CHAIN REACTION; RECTUM CARCINOMA; SINGLE NUCLEOTIDE POLYMORPHISM; STOMACH ADENOCARCINOMA; STOMACH CANCER;

ADENOCARCINOMA; COLORECTAL NEOPLASMS; FEMALE; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; IRAN; MALE; POLYMERASE CHAIN REACTION; POLYMORPHISM, SINGLE NUCLEOTIDE; STOMACH NEOPLASMS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 75749155863     PISSN: 0019509X     EISSN: 19984774     Source Type: Journal    
DOI: 10.4103/0019-509X.58856     Document Type: Article

References (21)

1. DeLeo AB, Jay G, Appella E, Dubois GC, Law LW, Old LJ. Detection of a transformation-related antigen in chemically induced sarcomas and other transformed cells of the mouse. Proc Natl Acad Sci U S A 1979;76:2420-2424
2. Levine AJ. p53, the cellular gatekeeper for growth and division. Cell 1997;88:323-331
3. Parkin DM, Bray F, Ferlay J, Pisani P. Global cancer statistics, 2002. CA Cancer J Clin 2005;55:74-108.
4. Sadjadi A, Nouraie M, Mohagheghi MA, Mousavi-Jarrahi A, Malekezadeh R, Parkin DM. Cancer occurrence in Iran in 2002, an international perspective. Asian Pac J Cancer Prev 2005;6:359-363
5. Hamajima N, Matsuo K, Suzuki T, Nakamura T, Matsuura A, Hatooka S, et al. No associations of p73 G4C14-to-A4T14 at exon 2 and p53 Arg72Pro polymorphisms with the risk of digestive tract cancers in Japanese. Cancer Lett 2002;181:81-85
6. Koushik A, Tranah GJ, Ma J, Stampfer MJ, Sesso HD, Fuchs CS, et al. p53 Arg72Pro polymorphism and risk of colorectal adenoma and cancer. Int J Cancer 2006;119:1863-1868
7. Mammano E, Belluco C, Bonafe M, Olivieri F, Mugianesi E, Barbi C, et al. Association of p53 polymorphisms and colorectal cancer: Modulation of risk and progression. Eur J Surg Oncol 2009;35:415-419
8. Jones JS, Chi X, Gu X, Lynch PM, Amos CI, Frazier ML. p53 polymorphism and age of onset of hereditary nonpolyposis colorectal cancer in a Caucasian population. Clin Cancer Res 2004;10:5845-5849 (Pubitemid 39180964)
9. Talseth BA, Meldrum C, Suchy J, Kurzawski G, Lubinski J, Scott RJ. Age of diagnosis of colorectal cancer in HNPCC patients is more complex than that predicted by R72P polymorphism in TP53. Int J Cancer 2006;118:2479-2484
10. Khayat AS, Lobo Gatti L, Moura Lima E, de Assumpcao PP, Nascimento Motta FJ, Harada ML, et al. Polymorphisms of the TP53 codon 72 and WRN codon 1367 in individuals from Northern Brazil with gastric adenocarcinoma. Clin Exp Med 2005;5:161-168
11. Sotamaa K, Liyanarachchi S, Mecklin JP, Jarvinen H, Aaltonen LA, Peltomaki P, et al. p53 codon 72 and MDM2 SNP309 polymorphisms and age of colorectal cancer onset in Lynch syndrome. Clin Cancer Res 2005;11:6840-6844
12. SharifiR, Allameh A, Biramijamal F, Mohammadzadeh SH, Rasmi Y, Tavangar SM, et al. Relationship between genetic polymorphism of glutathione S-transferase-p1 and p53 protein accumulation in Iranian esophageal squamous cell carcinoma patients. Indian J Cancer 2008;45:8-12.
13. Zhang ZW, Newcomb P, Hollowood A, Feakins R, Moorghen M, Storey A, et al. Age-associated increase of codon 72 Arginine p53 frequency in gastric cardia and non-cardia adenocarcinoma. Clin Cancer Res 2003;9:2151-2156
14. Matakidou A, Eisen T, Houlston RS. TP53 polymorphisms and lung cancer risk: a systematic review and meta-analysis. Mutagenesis 2003;18:377-385
15. Buchman VL, Chumakov PM, Ninkina NN, Samarina OP, Georgiev GP. A variation in the structure of the protein-coding region of the human p53 gene. Gene 1988;70:245-252
16. Thomas M, Kalita A, Labrecque S, Pim D, Banks L, Matlashewski G. Two polymorphic variants of wild-type p53 differ biochemically and biologically. Mol Cell Biol 1999;19:1092-1100
17. Shepherd T, Tolbert D, Benedetti J, Macdonald J, Stemmermann G, Wiest J, et al. Alterations in exon 4 of the p53 gene in gastric carcinoma. Gastroenterology 2000;118:1039-1044
18. Miller SA, Dykes DD, Polesky HF. A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 1988;16:1215.
19. Khadang B, Fattahi MJ, Talei A, Dehaghani AS, Ghaderi A. Polymorphism of TP53 codon 72 showed no association with breast cancer in Iranian women. Cancer Genet Cytogenet 2007;173:38-42.
20. Liu C, Crawford JM. The gastrointestinal tract. In: Pathologic basis of disease. Kumar v, Abbas Ak, Fausto N, editors. Philadelphia: Elsevier; 2005. p. 797-875.
21. Langerod A, Bukholm IR, Bregard A, Lonning PE, Andersen TI, Rognum TO, et al. The TP53 codon 72 polymorphism may affect the function of TP53 mutations in breast carcinomas but not in colorectal carcinomas. Cancer Epidemiol Biomarkers Prev 2002;11:1684-1688